Measuring the Physiologic Properties of Oral Lesions Receiving Fractionated Photodynamic Therapy

Photodynamic therapy (PDT) can treat superficial, early‐stage disease with minimal damage to underlying tissues and without cumulative dose‐limiting toxicity. Treatment efficacy is affected by disease physiologic properties, but these properties are not routinely measured. We assessed diffuse reflectance spectroscopy (DRS) for the noninvasive, contact measurement of tissue hemoglobin oxygen saturation (StO2) and total hemoglobin concentration ([tHb]) in the premalignant or superficial microinvasive oral lesions of patients treated with 5‐aminolevulinic acid (ALA)‐PDT. Patients were enrolled on a Phase 1 study of ALA‐PDT that evaluated fluences of 50, 100, 150 or 200 J cm−2 delivered at 100 mW cm−2. To test the feasibility of incorporating DRS measurements within the illumination period, studies were performed in patients who received fractionated (two‐part) illumination that included a dark interval of 90–180 s. Using DRS, tissue oxygenation at different depths within the lesion could also be assessed. DRS could be performed concurrently with contact measurements of photosensitizer levels by fluorescence spectroscopy, but a separate noncontact fluorescence spectroscopy system provided continuous assessment of photobleaching during illumination to greater tissue depths. Results establish that the integration of DRS into PDT of early‐stage oral disease is feasible, and motivates further studies to evaluate its predictive and dosimetric value.

[1]  David Kessel,et al.  Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.

[2]  Tayyaba Hasan,et al.  Pretreatment photosensitizer dosimetry reduces variation in tumor response. , 2006, International journal of radiation oncology, biology, physics.

[3]  H. S. de Bruijn,et al.  Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall. , 2013, Journal of Photochemistry and Photobiology. B: Biology.

[4]  Brian W Pogue,et al.  Tumor PO(2) changes during photodynamic therapy depend upon photosensitizer type and time after injection. , 2002, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[5]  Stanley B. Brown,et al.  Protoporphyrin IX Fluorescence Photobleaching during ALA‐Mediated Photodynamic Therapy of UVB‐Induced Tumors in Hairless Mouse Skin , 1999, Photochemistry and photobiology.

[6]  B. Wilson,et al.  The physics, biophysics and technology of photodynamic therapy , 2008, Physics in medicine and biology.

[7]  Stefan Andersson-Engels,et al.  In vivo measurement of parameters of dosimetric importance during interstitial photodynamic therapy of thick skin tumors. , 2006, Journal of biomedical optics.

[8]  K. Aoki,et al.  Physiological gas exchange in the middle ear cavity. , 2002, International journal of pediatric otorhinolaryngology.

[9]  H. S. de Bruijn,et al.  The effect of fluence rate on the acute response of vessel diameter and red blood cell velocity during topical 5-aminolevulinic acid photodynamic therapy. , 2014, Photodiagnosis and photodynamic therapy.

[10]  Ulas Sunar,et al.  Monitoring blood flow responses during topical ALA-PDT , 2010, Biomedical optics express.

[11]  J. Roodenburg,et al.  Non-invasive measurement of the morphology and physiology of oral mucosa by use of optical spectroscopy. , 2007, Oral oncology.

[12]  Jarod C Finlay,et al.  Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling , 2010, Journal of biophotonics.

[13]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[14]  Michael J. Emanuele,et al.  Treatment-Induced Changes in Tumor Oxygenation Predict Photodynamic Therapy Outcome , 2004, Cancer Research.

[15]  E. Hull,et al.  Porphyrin Bleaching and PDT-induced Spectral Changes are Irradiance Dependent in ALA-sensitized Normal Rat Skin In Vivo¶ , 2001, Photochemistry and photobiology.

[16]  Alison Curnow,et al.  Light Dose Fractionation to Enhance Photodynamic Therapy Using 5‐Aminolevulinic Acid in the Normal Rat Colon , 1999, Photochemistry and photobiology.

[17]  Jarod C Finlay,et al.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. , 2005, Journal of photochemistry and photobiology. B, Biology.

[18]  Monitoring microcirculatory alterations in oral squamous cell carcinoma following photodynamic therapy. , 2012, Photodiagnosis and photodynamic therapy.

[19]  T. Busch,et al.  Local physiological changes during photodynamic therapy , 2006, Lasers in surgery and medicine.

[20]  A. Curnow,et al.  Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. , 2000, Journal of photochemistry and photobiology. B, Biology.

[21]  Alison Curnow,et al.  The relationship between protoporphyrin IX photobleaching during real‐time dermatological methyl‐aminolevulinate photodynamic therapy (MAL‐PDT) and subsequent clinical outcome , 2010, Lasers in surgery and medicine.

[22]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.

[23]  Timothy C. Zhu,et al.  PDT dose dosimetry for pleural photodynamic therapy , 2013, Photonics West - Biomedical Optics.

[24]  Stanley B. Brown,et al.  Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.

[25]  Paul M Speight,et al.  Update on Oral Epithelial Dysplasia and Progression to Cancer , 2007, Head and neck pathology.

[26]  M. Biel,et al.  Photodynamic therapy of head and neck cancers. , 2010, Methods in molecular biology.

[27]  Frank Verhaegen,et al.  Spectroscopic characterization of a novel electronic brachytherapy system , 2008, Physics in medicine and biology.

[28]  Jarod C Finlay,et al.  Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma. , 2011, Photodiagnosis and photodynamic therapy.

[29]  Michele M. Kim,et al.  PDT dose dosimeter for pleural photodynamic therapy , 2016, SPIE BiOS.

[30]  M G Nichols,et al.  Quantitative broadband near-infrared spectroscopy of tissue-simulating phantoms containing erythrocytes. , 1998, Physics in medicine and biology.

[31]  B. Döme,et al.  Vascularization of cutaneous melanoma involves vessel co‐option and has clinical significance , 2002, The Journal of pathology.

[32]  Cristina Kurachi,et al.  Noninvasive evaluation of oral lesions using depth‐sensitive optical spectroscopy , 2009, Cancer.

[33]  B W Henderson,et al.  Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. , 1987, Cancer research.

[34]  D. Lübbers,et al.  The cutaneous uptake of atmospheric oxygen contributes significantly to the oxygen supply of human dermis and epidermis , 2002, The Journal of physiology.

[35]  Jarod C Finlay,et al.  Interstitial Fluorescence Spectroscopy in the Human Prostate During Motexafin Lutetium–Mediated Photodynamic Therapy , 2006, Photochemistry and photobiology.

[36]  J. Mourant,et al.  Predictions and measurements of scattering and absorption over broad wavelength ranges in tissue phantoms. , 1997, Applied optics.

[37]  Ken Kang-Hsin Wang,et al.  Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals. , 2008, Medical physics.

[38]  Jarod C Finlay,et al.  Hemoglobin oxygen saturations in phantoms and in vivo from measurements of steady-state diffuse reflectance at a single, short source-detector separation. , 2004, Medical physics.

[39]  Ulas Sunar,et al.  Monitoring photodynamic therapy of head and neck malignancies with optical spectroscopies. , 2013, World journal of clinical cases.

[40]  V. Schacht,et al.  Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[41]  Soren D. Konecky,et al.  Spatial frequency domain tomography of protoporphyrin IX fluorescence in preclinical glioma models. , 2012, Journal of biomedical optics.

[42]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[43]  K. Soo,et al.  Hemodynamic monitoring of Chlorin e6-mediated photodynamic therapy using diffuse optical measurements. , 2014, Journal of photochemistry and photobiology. B, Biology.

[44]  J. Roodenburg,et al.  Non-invasive measurement of the microvascular properties of non-dysplastic and dysplastic oral leukoplakias by use of optical spectroscopy. , 2011, Oral oncology.

[45]  Brian Pogue,et al.  Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema , 2014, Journal of biomedical optics.

[46]  Rebecca Richards-Kortum,et al.  Autofluorescence and diffuse reflectance spectroscopy of oral epithelial tissue using a depth-sensitive fiber-optic probe. , 2008, Applied optics.

[47]  Targeted laryngeal photodynamic therapy with a balloon diffusing light source. , 2010, Photodiagnosis and photodynamic therapy.

[48]  Jarod C Finlay,et al.  Quantitative comparison of tissue oxygen and motexafin lutetium uptake by ex vivo and noninvasive in vivo techniques in patients with intraperitoneal carcinomatosis. , 2007, Journal of biomedical optics.

[49]  Ken Kang-Hsin Wang,et al.  Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA‐PDT , 2009, Lasers in surgery and medicine.

[50]  Ulas Sunar,et al.  Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging , 2013, Biomedical optics express.

[51]  Thomas H Foster,et al.  Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas , 2008, Clinical Cancer Research.